WO2009066537A1 - Inducteur de fonction immunorégulatrice et composition alimentaire - Google Patents

Inducteur de fonction immunorégulatrice et composition alimentaire Download PDF

Info

Publication number
WO2009066537A1
WO2009066537A1 PCT/JP2008/069210 JP2008069210W WO2009066537A1 WO 2009066537 A1 WO2009066537 A1 WO 2009066537A1 JP 2008069210 W JP2008069210 W JP 2008069210W WO 2009066537 A1 WO2009066537 A1 WO 2009066537A1
Authority
WO
WIPO (PCT)
Prior art keywords
lactic acid
acid bacterium
processed product
bacterium
food composition
Prior art date
Application number
PCT/JP2008/069210
Other languages
English (en)
Japanese (ja)
Inventor
Seiya Makino
Shuji Ikegami
Noriko Tsuji
Original Assignee
Meiji Dairies Corporation
National Institute Of Advanced Industrial Science And Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Dairies Corporation, National Institute Of Advanced Industrial Science And Technology filed Critical Meiji Dairies Corporation
Priority to JP2009542511A priority Critical patent/JP5527690B2/ja
Publication of WO2009066537A1 publication Critical patent/WO2009066537A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/746—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for lactic acid bacteria (Streptococcus; Lactococcus; Lactobacillus; Pediococcus; Enterococcus; Leuconostoc; Propionibacterium; Bifidobacterium; Sporolactobacillus)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/46—Streptococcus ; Enterococcus; Lactococcus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Plant Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

L'invention vise à proposer une bactérie d'acide lactique appartenant au genre Lactococcus, qui a un effet anti-inflammatoire élevé sur une affection intestinale inflammatoire. Ainsi, l'invention porte sur : une bactérie d'acide lactique appartenant au genre Lactococcus, telle qu'exemplifiée par la souche OLS3301 de Lactococcus lactis et/ou un produit traité de la bactérie d'acide lactique; un inducteur de fonction immunorégulatrice comprenant la bactérie d'acide lactique et/ou le produit traité de la bactérie d'acide lactique en tant qu'ingrédient actif; et une composition alimentaire contenant une quantité efficace de la bactérie d'acide lactique et/ou du produit traité de la bactérie d'acide lactique. La bactérie et/ou le produit traité de celle-ci sont capables d'amener un immunocyte à produire IL-10, qui est une cytokine anti-inflammatoire, en grande quantité, et, par conséquent, peuvent empêcher une inflammation provoquée par une réponse inflammatoire en excès. La bactérie et/ou le produit traité de celle-ci peuvent également empêcher une inflammation de la peau.
PCT/JP2008/069210 2007-11-19 2008-10-23 Inducteur de fonction immunorégulatrice et composition alimentaire WO2009066537A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2009542511A JP5527690B2 (ja) 2007-11-19 2008-10-23 免疫調節性機能誘導剤及び食品組成物

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007298754 2007-11-19
JP2007-298754 2007-11-19

Publications (1)

Publication Number Publication Date
WO2009066537A1 true WO2009066537A1 (fr) 2009-05-28

Family

ID=40667364

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/069210 WO2009066537A1 (fr) 2007-11-19 2008-10-23 Inducteur de fonction immunorégulatrice et composition alimentaire

Country Status (2)

Country Link
JP (1) JP5527690B2 (fr)
WO (1) WO2009066537A1 (fr)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011148710A (ja) * 2010-01-19 2011-08-04 Snow Brand Milk Prod Co Ltd 炎症性腸疾患及び／又は過敏性腸症候群の予防及び／又は治療剤
JP2014501100A (ja) * 2010-12-17 2014-01-20 コンパニ・ジェルベ・ダノン 消化器の病的状態の改善に使用するためのラクトコッカスラクティス株
JP6298912B1 (ja) * 2017-04-10 2018-03-20 有限会社バイオ研 乳酸菌の製造方法、及び免疫調節用組成物
JP2018078832A (ja) * 2016-11-16 2018-05-24 株式会社明治 微生物の加熱処理方法
KR102154254B1 (ko) * 2020-04-29 2020-09-09 (주)녹십자웰빙 우수한 면역기능 증진 효과를 갖는 신규한 유산균 및 이를 포함하는 식품조성물, 건강기능성 식품 조성물 및 프로바이오틱스
US10806769B2 (en) 2016-03-31 2020-10-20 Gojo Industries, Inc. Antimicrobial peptide stimulating cleansing composition
CN111818812A (zh) * 2018-03-15 2020-10-23 麒麟控股株式会社 皮肤状态改善用组合物
US10874700B2 (en) 2016-03-31 2020-12-29 Gojo Industries, Inc. Sanitizer composition with probiotic/prebiotic active ingredient
US11466582B2 (en) 2016-10-12 2022-10-11 General Electric Company Turbine engine inducer assembly
US11564879B2 (en) 2016-11-23 2023-01-31 Gojo Industries, Inc. Sanitizer composition with probiotic/prebiotic active ingredient
CN116121110A (zh) * 2022-10-28 2023-05-16 益加生物科技成都有限公司 一种抑菌和抗炎作用较强的乳酸乳球菌yj0801及其应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005154387A (ja) * 2003-11-28 2005-06-16 National Institute Of Agrobiological Sciences 免疫調節性機能を誘導する乳酸菌類・成分とその取得方法
JP2007269737A (ja) * 2006-03-31 2007-10-18 Morinaga Milk Ind Co Ltd インターロイキン産生調節剤、該インターロイキン産生調節剤を含む医薬組成物及び飲食品、並びにその製造方法

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005154387A (ja) * 2003-11-28 2005-06-16 National Institute Of Agrobiological Sciences 免疫調節性機能を誘導する乳酸菌類・成分とその取得方法
JP2007269737A (ja) * 2006-03-31 2007-10-18 Morinaga Milk Ind Co Ltd インターロイキン産生調節剤、該インターロイキン産生調節剤を含む医薬組成物及び飲食品、並びにその製造方法

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
HIROMI KIMOTO ET AL.: "Nyugyoyo Nyusankin Lactococcus no Men'eki Chosetsu Sayo ni tsuite", JOURNALOF JAPANESE SOCIETY OF NUTRITION, AND FOOD SCIENCE SOKAI KOEN YOSHISHU, vol. 58TH, 2004, pages 123 *
MAKINO S. ET AL.: "Immunomodulatory efects of Lactococcus lactis subsp. lactis OLS3301 on dextran sulfate sodium-induced colitis in mice.", DAI 37 KAI PROCEEDINGS OF THE JAPANESE SOCIETY FOR IMMUNOLOGY, vol. 37, October 2007 (2007-10-01), pages 161 *
NORIKO TSUJI ET AL.: "IL-10 Sansei o Unagashi Men'eki Chosetsu ni Hataraku Probiotics", NIPPON NOGEI KAGAKUKAI TAIKAI KOEN YOSHISHU, vol. 2004, 2004, pages 217 *

Cited By (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011148710A (ja) * 2010-01-19 2011-08-04 Snow Brand Milk Prod Co Ltd 炎症性腸疾患及び／又は過敏性腸症候群の予防及び／又は治療剤
JP2014501100A (ja) * 2010-12-17 2014-01-20 コンパニ・ジェルベ・ダノン 消化器の病的状態の改善に使用するためのラクトコッカスラクティス株
US10874700B2 (en) 2016-03-31 2020-12-29 Gojo Industries, Inc. Sanitizer composition with probiotic/prebiotic active ingredient
US11998575B2 (en) 2016-03-31 2024-06-04 Gojo Industries, Inc. Sanitizer composition with probiotic/prebiotic active ingredient
US10806769B2 (en) 2016-03-31 2020-10-20 Gojo Industries, Inc. Antimicrobial peptide stimulating cleansing composition
US11633451B2 (en) 2016-03-31 2023-04-25 Gojo Industries, Inc. Antimicrobial peptide stimulating cleansing composition
US11846209B2 (en) 2016-10-12 2023-12-19 General Electric Company Turbine engine inducer assembly
US11466582B2 (en) 2016-10-12 2022-10-11 General Electric Company Turbine engine inducer assembly
JP2018078832A (ja) * 2016-11-16 2018-05-24 株式会社明治 微生物の加熱処理方法
WO2018092678A1 (fr) * 2016-11-16 2018-05-24 株式会社明治 Procédé de traitement thermique pour micro-organisme
US11564879B2 (en) 2016-11-23 2023-01-31 Gojo Industries, Inc. Sanitizer composition with probiotic/prebiotic active ingredient
JP2018174772A (ja) * 2017-04-10 2018-11-15 有限会社バイオ研 乳酸菌の製造方法、及び免疫調節用組成物
JP6298912B1 (ja) * 2017-04-10 2018-03-20 有限会社バイオ研 乳酸菌の製造方法、及び免疫調節用組成物
EP3766363A4 (fr) * 2018-03-15 2022-01-05 Kirin Holdings Kabushiki Kaisha Composition permettant d'améliorer des problèmes de peau
US11497778B2 (en) 2018-03-15 2022-11-15 Kirin Holdings Kabushiki Kaisha Composition for improving skin conditions
CN111818812B (zh) * 2018-03-15 2023-09-26 麒麟控股株式会社 皮肤状态改善用组合物
CN111818812A (zh) * 2018-03-15 2020-10-23 麒麟控股株式会社 皮肤状态改善用组合物
AU2019233471B2 (en) * 2018-03-15 2024-03-28 Kirin Holdings Kabushiki Kaisha Composition for improving skin conditions
KR102154254B1 (ko) * 2020-04-29 2020-09-09 (주)녹십자웰빙 우수한 면역기능 증진 효과를 갖는 신규한 유산균 및 이를 포함하는 식품조성물, 건강기능성 식품 조성물 및 프로바이오틱스
CN116121110A (zh) * 2022-10-28 2023-05-16 益加生物科技成都有限公司 一种抑菌和抗炎作用较强的乳酸乳球菌yj0801及其应用

Also Published As

Publication number Publication date
JP5527690B2 (ja) 2014-06-18
JPWO2009066537A1 (ja) 2011-04-07

Similar Documents

Publication Publication Date Title
WO2009066537A1 (fr) Inducteur de fonction immunorégulatrice et composition alimentaire
MY159379A (en) Composition for human and/or animal nutrition, uses thereof and yeasts
JP2013517784A5 (fr)
NZ602557A (en) Solid form of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
NZ611606A (en) Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
PH12014501254A1 (en) Lipid metabolism and/or sugar metabolism improver containing lactic acid bacterium or treatment product thereof
MX2012002343A (es) Agente contra la obesidad, alimento o bebida contra la obesidad, agente que mejora la tolerancia a la glucosa, y alimento o bebida para mejorar la tolerancia a la glucosa.
TW200700074A (en) Inducer of t cell apoptosis
NZ618734A (en) Polyunsaturated fatty acids for the treatment of diseases related to cardiovascular, metabolic and inflammatory disease areas
DE602005024156D1 (de) Lactobacillus rhamnosus mit körperfett reduzierender aktivität sowie diese enthaltende lebensmittel
WO2009005124A1 (fr) Arn double brin provenant d'une bactérie d'acide lactique
WO2010000877A3 (fr) Formulation à base de bisabolol et de [6]-paradol produisant un effet apaisant sur les irritations
WO2007053815A3 (fr) Compositions et procedes d'utilisation de produit de soin pour la peau a base de jus et de matiere organique
UA86349C2 (ru) Противоаллергический агент, его применение для снижения аллергии и способ уменьшения симптомов аллергии
WO2018093238A3 (fr) Composition comprenant en tant qu'ingrédient actif une souche présentant une excellente aptitude à produire de l'acide formique pour prévenir ou traiter l'obésité ou des syndromes métaboliques provoqués par l'obésité
NZ612732A (en) Hop oxidation-reaction product, preparing method thereof and use thereof
WO2012040804A3 (fr) Combinaisons synergiques de triazoles, strobilurines et de benzimidazoles, leurs utilisations, formulations, leurs procédés de production et leurs applications
EP1538198A3 (fr) Induction de fonctions immuno-régulatrices par des bactéries d' acide lactique, et méthodes pour les obtenir
JP2014500263A5 (fr)
FI20075539A0 (fi) Maitohappobakteerit, joilla on proinflammatorisia ominaisuuksia
WO2009061152A3 (fr) Composition pour la prévention et le traitement de la douleur contenant de la curcumine ou un sel pharmaceutiquement acceptable de celle-ci comme ingrédient actif
WO2008099801A1 (fr) Procédé pour améliorer la viabilité d'une bactérie d'acide lactique
WO2005087017A3 (fr) Compositions comportant des isomeres inverses d'acide linoleique conjugue
WO2009112558A3 (fr) Composition comprenant de l’aloès pur, et son utilisation comme base cosmétique
GR20110100600A (el) Λειτουργικες επιτραπεζιες ελιες ζυμωμενες με γαλακτικα βακτηρια που διαθετουν προβιοτικες ιδιοτητες

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08851225

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 2009542511

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08851225

Country of ref document: EP

Kind code of ref document: A1